996 Federal Register / Vol. 75, No. 4 / Thursday, January 7, 2010 / Notices 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3198, 

MSC 7808, Bethesda, MD 20892, 301–435– 

2306, boundst@csr.nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies; Community-Level Health 

Promotion Study Section. 

Date: February 4–5, 2010. 

Time: 8:30 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Monaco, 495 Geary Street, San 

Francisco, CA 94102. 

Contact Person: Jacinta Bronte-Tinkew, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3164, 

MSC 7770, Bethesda, MD 20892, (301) 435– 

1503, brontetinkewjm@csr.nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group Adult Psychopathology and Disorders 

of Aging Study Section. 

Date: February 4–5, 2010. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Ave., NW., Washington, DC 20037. 

Contact Person: Estina E. Thompson, PhD, 

MPH, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3178, 

MSC 7848, Bethesda, MD 20892, 301–496– 

5749, thompsone@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Neurotechnology 2. 

Date: February 5, 2010. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Westin St. Francis, 335 Powell 

Street, San Francisco, CA 94102. 

Contact Person: Robert C. Elliott, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3130, 

MSC 7850, Bethesda, MD 20892, 301–435– 

3009, elliotro@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: December 30, 2009. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–35 Filed 1–6–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Medicare Prescription Drug, 

Improvement, and Modernization Act 

of 2003 Section 1013: Request for 

Nominations—The Effective Health 

Care Stakeholder Group 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), DHHS. 

ACTION: Notice of invitation to submit 

nominations for the Effective Health 

Care Stakeholder Group. 

SUMMARY: The DHHS Agency for 

Healthcare Research and Quality 

(AHRQ) invites nominations from 

interested organizations and 

knowledgeable individuals for members 

of the Stakeholder Group to support the 

work of the Effective Health Care 

Program, established [for consultation] 

pursuant to Section 1013 of the 

Medicare Prescription Drug, 

Improvement, and Modernization Act 

(MMA) of 2003. The goals of this 

program are to develop evidence on the 

effectiveness and comparative 

effectiveness of different treatments and 

health care interventions of importance 

to the Medicare, Medicaid, and State 

Child Health Insurance programs. To 

achieve these goals, AHRQ supports 

projects to review, synthesize, generate, 

and translate scientific evidence, as well 

as identify important issues for which 

existing scientific evidence is 

insufficient to inform decisions about 

health care. The Effective Health Care 

Program makes the evidence 

information it develops readily available 

to health care decision makers. The 

Stakeholder Group is critical to the 

success of the Effective Health Care 

Program by providing input to improve 

the applicability and relevance of 

research products to health care 

decision makers. The Effective Health 

Care Program Stakeholder Group will be 

a part of the Citizen’s Forum initiative, 

funded by the American Recovery and 

Reinvestment Act, to formally and 

broadly engage stakeholders, and to 

enhance and expand public 

involvement in the entire Effective 

Health Care enterprise. 

The role of the Stakeholder Group will 

be to: 

• Provide guidance on program 

implementation including: 

i. Quality improvement. 

ii. Opportunities to maximize impact 

and expand program reach. 

iii. Ensuring stakeholder interests are 

considered and included. 

iv. Evaluating success. 

• Provide input on implementing 

Effective Health Care Program reports 

and findings in practice and policy 

settings. 

• Identify options and recommend 

solutions to issues identified by 

Effective Health Care Program staff. 

• Provide input on critical research 

information gaps for practice and 

policy, as well as research methods to 

address them. Specifically: 

i. Information needs and types of 

products most useful to consumers, 

clinicians and policy makers. 

ii. Feedback on Effective Health Care 

Program reports, reviews and summary 

guides. 

iii. Scientific methods and 

applications. 

• Champion objectivity, 

accountability and transparency in the 

Effective Health Care program. 

Members will serve as volunteers for 

a two-year period from summer 2010 

through summer 2012. Stakeholder 

Group members will attend 3–4 

meetings per year in Rockville, MD, and 

possibly other cities to be determined. 

Meetings will be 1–2 days in length, and 

AHRQ or a group designated by AHRQ 

will be responsible for travel planning 

and expenses. The first meeting will be 

held in late summer or early fall 2010 

in Rockville, MD. 

Members are expected to actively 

participate in meetings and to engage in 

related activities by phone and e-mail 

between meetings. Between-meeting 

work may include reviewing and 

providing input on the overall product 

development strategy and direction for 

the Effective Health care program, 

consulting with AHRQ staff on 

constituency issues, and serving as a 

resource to the Program. It is anticipated 

that the Stakeholder Group member 

time commitment between meetings 

will not exceed 10 hours. 

The Stakeholder Group will be 

composed of up to 20 members with a 

diversity of perspectives and opinions. 

The group will represent several broad 

constituencies of stakeholders and 

decision-makers at the policy, system, 

and clinical levels, which will include: 

• Patient/caregiver/consumer. 

• Consumers of Federal and State 

beneficiary programs. 

• Healthcare providers. 

• Third party healthcare payers 

(including, but not limited to public 

State or Federal Medicare or Medicaid 

programs, and private insurance health 

plans and Health Maintenance 

Organizations). 

• Employers and health-related 

businesses. 

• Pharmacy and therapeutic 

committees. 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES

Federal Register / Vol. 75, No. 4 / Thursday, January 7, 2010 / Notices 997 

• Healthcare, industry, and 

professional organizations. 

• Academic researchers (including, 

but not limited to, those with expertise 

in evidence-based methods and 

effectiveness and translational research). 

Self-nominations are encouraged. 

Materials to be submitted include a 

cover letter and curriculum vitae or 

similar supportive documentation. The 

cover letter should provide information 

on how the nominee’s experience, skills 

and roles would help to reflect the 

diverse perspectives and expertise of the 

group and help to address the functions 

and goals of the Stakeholder Group as 

described above. Specific information 

on nominee experience in the 

constituency groups described above is 

required. If nominating a second party, 

a statement of the nominee’s permission 

and willingness to serve must be 

provided. Nominees chosen for the 

Stakeholder Group will be required to 

declare and submit conflict of interest 

documentation. Nominees may indicate 

their willingness to be considered in 

subsequent calls for nominations if not 

selected for this Stakeholder Group. 

All nominations received by the 

submission deadline will be reviewed 

by a committee composed of 

representatives from AHRQ. Nominees 

who best represent the broad 

constituencies sought for composition of 

the Stakeholder Group as described 

above, will be selected and notified by 

May 7, 2010. 

DATES: Nominations for the Effective 

Health Care Stakeholder Group must be 

received by February 8, 2010. 

ADDRESSES: Nominations for 

consideration may be e-mailed to 

EffectiveHealthCare@AHRQ.gov. 

FOR FURTHER INFORMATION CONTACT: 

Effective Health Care Program at (301) 

427–1502 or 

EffectiveHealthCare@AHRQ.gov. 

More information about the Effective 

Health Care Program is available at 

http://www.EffectiveHealthCare. 

AHRQ.gov. 

SUPPLEMENTARY INFORMATION: Nominees 

not selected for the Stakeholder Group 

are invited to participate in the Effective 

Healthcare Program by making 

suggestions for research and providing 

comment on key questions and draft 

reviews. A listserv has been established 

and everyone interested may join to be 

notified when items become available 

for review or public comment. 

Opportunities for involvement in the 

Effective Health Care Program are 

described at http:// 

www.EffectiveHealthCare.AHRQ.gov. 

Dated: December 22, 2009. 

Carolyn M. Clancy, 

Director. 

[FR Doc. E9–31341 Filed 1–6–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2007–28460] 

Record of Decision (ROD) on the U.S. 

Coast Guard Long Range Aids to 

Navigation (Loran-C) Program 

AGENCY: Coast Guard, DHS. 

ACTION: Notice of availability. 

SUMMARY: The Department of Homeland 

Security (DHS), United States Coast 

Guard (USCG), announces the 

availability of the Record of Decision 

(ROD) to decommission the USCG 

Loran-C Program and terminate 

transmission of the North American 

Loran-C Radionavigation Signal. The 

ROD is supported by the Final 

Programmatic Environmental Impact 

Statement (PEIS) addressing the future 

of the USCG Loran-C Program. The 

Final PEIS availability was announced 

by the Environmental Protection Agency 

(EPA) on June 12, 2009 (74 FR 28046). 

DATES: The Final PEIS and ROD are now 

available in the docket. The USCG 

intends to begin termination of the 

broadcast of the North American LoranC Radionavigation Signal beginning on 

or about February 8, 2010. Loran 

stations are expected to cease 

transmitting the Loran-C 

radionavigation signal by October 1, 

2010. 

ADDRESSES: To view the ROD or the 

Final PEIS, go to http:// 

www.regulations.gov, insert USCG– 

2007–28460 in the ‘‘Keyword’’ box, and 

then click ‘‘Search.’’ Project documents, 

including the Final PEIS, are also 

available on the ‘‘USCG Long Range 

Aids to Navigation (Loran-C) Program’’ 

Web site at http://loranpeis.uscg.e2minc.com/. If access to the Internet is not 

available, you may view the docket 

online by visiting the Docket 

Management Facility in Room W12–140 

on the ground floor of the Department 

of Transportation West Building, 1200 

New Jersey Avenue, SE., Washington, 

DC 20590, between 9 a.m. and 5 p.m., 

Monday through Friday, except Federal 

holidays. 

FOR FURTHER INFORMATION CONTACT: If 

there are questions on this notice, call 

LCDR Robert Manning, Electronic 

Navigation Division, USCG, telephone 

202–372–1560, or e-mail 

robert.j.manning@uscg.mil. If you have 

questions on viewing or submitting 

material to the docket, call Renee V. 

Wright, Program Manager, Docket 

Operations, telephone 202–366–9826. 

Background and Purpose 

Loran is a radionavigation system first 

developed during World War II and 

operated by the USCG. The current 

Loran-C system is a low frequency 

hyperbolic radionavigation system 

approved for use in the Coastal 

Confluence Zone and as a supplemental 

air navigation aid. The Loran-C 

radionavigation system provides 

navigation, location, and timing services 

for both civil and military air, land, and 

marine users in the continental United 

States (CONUS) and Alaska. The USCG 

operates 18 CONUS Loran Stations, 6 

Alaska Loran Stations, and 24 

monitoring sites. 

On January 22, 2009 (74 FR 4047), the 

USCG made available the Draft PEIS. 

The USCG delivered the Final PEIS 

addressing the future of the USCG 

Loran-C Program to the EPA, and the 

EPA announced the availability of the 

Final PEIS on June 12, 2009 (74 FR 

28046). 

By separate notice published today in 

the Federal Register, the USCG advised 

the public of the USCG’s intention to 

begin planning for the termination of 

the broadcast of the North American 

Loran-C Radionavigation Signal 

beginning on or about February 8, 2010. 

The USCG advised that if plans were 

implemented, Loran stations would 

cease transmitting the Loran-C 

radionavigation signal by October 1, 

2010. 

The Final PEIS on the future of the 

USCG Loran-C Program is a programlevel document that provided the USCG 

with high-level analysis of the potential 

impacts on the human environment 

from the alternatives for the future of 

the USCG Loran-C Program. The Final 

PEIS evaluated the following five 

alternatives on the future of the USCG 

Loran-C Program: 

(1) No Action Alternative. The No 

Action Alternative refers to the current, 

existing conditions without 

implementation of the Proposed Action. 

(2) Decommission the USCG Loran-C 

Program and Terminate the North 

American Loran-C Radionavigation 

Signal. 

(3) Automate, Secure, and Unstaff 

Loran-C Stations. 

(4) Automate, Secure, Unstaff, and 

Transfer Management of the Loran-C 

Program to Another Government 

Agency. 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES